| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 63.62B | 62.50B | 61.06B | 46.46B | 49.15B | 48.63B |
| Gross Profit | 9.50B | 8.99B | 8.22B | 6.53B | 5.69B | 5.70B |
| EBITDA | 3.99B | 3.64B | 3.50B | 2.10B | 1.62B | 1.58B |
| Net Income | 2.27B | 2.49B | 1.96B | 1.47B | 974.26M | 1.14B |
Balance Sheet | ||||||
| Total Assets | 43.56B | 46.41B | 45.77B | 41.18B | 40.23B | 39.99B |
| Cash, Cash Equivalents and Short-Term Investments | 13.37B | 12.84B | 11.18B | 11.84B | 12.37B | 13.24B |
| Total Debt | 2.00B | 2.74B | 14.01M | 31.30M | 53.07M | 56.56M |
| Total Liabilities | 15.92B | 18.78B | 20.06B | 15.92B | 15.53B | 16.01B |
| Stockholders Equity | 27.63B | 27.63B | 25.71B | 25.26B | 24.70B | 23.98B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 87.92M | 2.85B | 488.34M | -606.59M | 5.15B |
| Operating Cash Flow | 0.00 | 560.79M | 3.01B | 719.55M | -533.45M | 7.50B |
| Investing Cash Flow | 0.00 | -113.91M | -767.73M | -241.43M | 42.69M | -2.21B |
| Financing Cash Flow | 0.00 | 1.14B | -3.22B | -1.38B | -878.34M | -495.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥34.83B | 9.14 | 7.87% | 3.40% | 0.81% | -26.70% | |
69 Neutral | ¥12.41B | 18.59 | ― | 1.24% | -2.82% | -44.93% | |
67 Neutral | ¥424.02B | -16.12 | 7.93% | 2.32% | -2.26% | -10.86% | |
67 Neutral | ¥58.01B | 7.15 | ― | 3.25% | 9.50% | 77.72% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
61 Neutral | ¥131.51B | 45.55 | 6.98% | 3.13% | -2.13% | 37.10% | |
49 Neutral | ¥17.96B | 743.26 | ― | 3.24% | -3.73% | -143.19% |